Skip to content

Maternal and Neonatal Effects of Dexmedetomidine with Etomidate Fat Emulsion for Caesarean Section under General Anaesthesia

Maternal and Neonatal Effects of Dexmedetomidine with Etomidate Fat Emulsion for Caesarean Section under General Anaesthesia

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2100048562
Enrollment
Unknown
Registered
2021-07-10
Start date
2021-07-01
Completion date
Unknown
Last updated
2022-03-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

cesarean section under general anesthesia

Interventions

Experimental group:Dexmedetomidine with Etomidate Fat Emulsion for Caesarean Section under General Anaesthesia
Control group:Routine induction under general anesthesia

Sponsors

The First Affiliated Hospital of USTC, Division of Life Sciences and Medicine, University of Science and Technology of China
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
No minimum to 40 Years

Inclusion criteria

Inclusion criteria: 1. Aged <=40, female; 2. Full-term pregnant women receiving elective cesarean section under general anesthesia; 3. ASA classification is I or major grade; 4. Have a junior high school education; 5. Clearly understand and voluntarily participate in the study, and sign the informed consent by himself or his legal client.

Exclusion criteria

Exclusion criteria: 1. Allergic to dexmedetomidine, etomidate and other general anesthetic drugs; 2. Heart, lung, liver, kidney, nervous system or neuromuscular diseases, morbital obesity, diabetes, anemia, bleeding disorders, exposure to cardiovascular, antipsychotic or hypnotic medications, alcohol or drug abuse; 3. Maternal women with evidence of gestational hypertension, intrauterine growth restriction or fetal distress; 4. A history of drug abuse, drug abuse and alcoholism within 2 years prior to the screening period, with alcoholism being more than 2 units of alcohol per day on average (1 unit =360mL beer or 45mL liquor with 40% alcohol or 150mL wine); 5. Patients considered by the investigator to be inappropriate to participate in this study.

Design outcomes

Primary

MeasureTime frame
Blood Pressure;Heart Rate;intraoperatve blood soss;Neonatal Apgar score;Neural Adaptability Score;

Countries

China

Contacts

Public ContactHe Keqiang

The First Affiliated Hospital of USTC, Division of Life Sciences and Medicine, University of Science and Technology of China

doctorhector@ustc.edu.cn+86 18955197569

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026